Aperçu rapide pour Epidermal Growth Factor (EGF) (Middle Region) Peptide (ABIN976172)
Antigène
EGF
(Epidermal Growth Factor (EGF))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
Middle Region
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-EGF antibody (Catalog #: ARP41486_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
EGF
Reactivité: Humain, Souris, Chien, Porc
Hôte: Synthetic
BP
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
EGF
(Epidermal Growth Factor (EGF))
Sujet
Epidermal growth factor has a profound effect on the differentiation of specific cells in vivo and is a potent mitogenic factor for a variety of cultured cells of both ectodermal and mesodermal origin. The EGF precursor is believed to exist as a membrane-
Alias Symbols: URG, HOMG4
Protein Interaction Partner: EGFR,EGFR,EGFR,ADAM12,ADRBK1,CPM,DUSP3,EGF,EGFR,ERBB2,ERBB3,GRB2,LMNA,NRG1,PIK3R2,VTN,EGF,EGFR,ERBB2,ERBB3,FNBP1,MAPKAPK2,PIK3R2,RPS6KA5,VTN